Suchergebnisse - "Menzies-Gow, Andrew"

PubPharm (247)

21

Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both

enthalten in: Allergy | 2023

von Pfeffer, P. | Ali, N. | Murray, R. | +66

22

Asthma exacerbations are associated with a decline in lung function : a longitudinal population-based study

enthalten in: Thorax | 2023

von Soremekun, S. | Heaney, L. | Skinner, D. | +14

23

Reply to Lipworth and Chan

enthalten in: American journal of respiratory and critical care medicine | July 15, 2023

von Ambrose, C. | Israel, E. | Bowen, K. | +10

24

Efficacy of tezepelumab in severe, uncontrolled asthma : pooled analysis of the PATHWAY and NAVIGATOR clinical trials

enthalten in: American journal of respiratory and critical care medicine | July 1, 2023

von Corren, J. | Menzies-Gow, A. | Chupp, G. | +13

25

Efficacy of Tezepelumab in Severe, Uncontrolled Asthma : Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials

enthalten in: American journal of respiratory and critical care medicine | 2023

von Corren, J. | Menzies-Gow, A. | Chupp, G. | +13

CommentIn: Ann Intern Med. 2023 Nov;176(11):JC128. - PMID 37931261

26

A Charter to Fundamentally Change the Role of Oral Corticosteroids in the Management of Asthma

enthalten in: Advances in therapy | 2023

von Haughney, J. | Winders, T. | Holmes, S. | +6

27

Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION) : a randomised, placebo-controlled extension study

enthalten in: The Lancet. Respiratory medicine | 2023

von Menzies-Gow, A. | Wechsler, M. | Brightling, C. | +114

CommentIn: Lancet Respir Med. 2023 Jan 23;:. - PMID 36702145

28

Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION) : a randomised, placebo-controlled extension study

enthalten in: The lancet / Respiratory medicine | 3 May 2023

von Menzies-Gow, A. | Wechsler, M. | Brightling, C. | +13

29

A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma : A Post Hoc Analysis by Sex

enthalten in: The journal of allergy and clinical immunology. In practice | 2023

von Eastwood, M. | Busby, J. | Jackson, D. | +23

30

Efficacy of tezepelumab in patients with evidence of severe allergic asthma : Results from the phase 3 NAVIGATOR study

enthalten in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology | 2023

von Corren, J. | Ambrose, C. | Griffiths, J. | +5